ªUniversity of Utah School of Medicine, Department of Dermatology, Salt Lake City, UT
BCleveland Clinic, Cleveland, OH
cDalhousie University, Division of Clinical Dermatology and Cutaneous Science, Halifax, Nova Scotia, Canada
DUniversity of British Columbia, Department of Dermatology and Skin Science, Vancouver, British Columbia, Canada
EKarolinska Institutet, Department of Medicine, Stockholm, Sweden
fJanssen Research & Development, LLC, Spring House, PA
gJanssen Scientific Affairs, LLC, Horsham, PA
PSOLAR is sponsored by Janssen Scientific Affairs, LLC, Horsham, PA.
AbbVie, Eli Lilly, Celgene, Janssen-Cilag, Novartis, Pfizer, and Wyeth Pharmaceuticals. Wayne Langholff, Kavitha Goyal, Steve Fakharzadeh, Claudia Galindo, and Bhaskar Srivastava are employees of Janssen Research & Development, LLC or Janssen Scientific Affairs, LLC, and may own company stock. Gerald Krueger received fees as a Consultant or Advisory Board member for Abbott, Amgen, Boehringer Ingleheim, Janssen Biotech, Eli Lilly, Novartis, Pfizer, PSOLAR/Johnson & Johnson, and Sun Pharma; lecture fees from Abbott, Amgen, Janssen Biotech, Novartis, and Eli Lilly; and received partial stipend support for a clinical research fellowship from Abbott and the National Psoriasis Foundation. All other authors do not have any conflicts of interests to declare.
This observational study was registered with ClinicalTrials.gov: NCT00508547. An institutional review board or ethics committee approved the PSOLAR protocol at each site, and the study was conducted in accordance with the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use guidelines on Good Clinical Practices and principles of the Declaration of Helsinki as well as other national and local laws and regulations, as appropriate.
Acknowledgments: The authors wish to thank Cynthia Arnold, BS (Janssen Scientific Affairs, LLC), and Chastity Bradley, PhD (Synchrogenix, A Certara Company), for providing editorial assistance and medical writing support for the manuscript.
References:
Chiesa Fuxench ZC, Shin DB, Ogdie Beatty A, et al. The risk of cancer in patients with psoriasis: A population-based cohort study in the health improvement network. JAMA Dermatol. 2016;152:282-290. doi: 10.1001/jamadermatol.2015.4847
Pouplard C, Brenaut E, Horreau C, et al. Risk of cancer in psoriasis: A systematic review and meta-analysis of epidemiological studies. J Eur Acad Dermatol Venereol. 2013;27 Suppl 3:36-46. doi: 10.1111/jdv.12165
Shelton E, Laharie D, Scott FI, et al. Cancer recurrence following immune-suppressive therapies in patients with immune-mediated diseases: A systematic review and meta-analysis. Gastroenterology. 2016;151:97-109.e104. doi: 10.1053/j.gastro.2016.03.037
Papp KA, Strober B, Augustin M, et al. PSOLAR: Design, utility, and preliminary results of a prospective, international, disease-based registry of patients with psoriasis who are receiving, or are candidates for, conventional systemic treatments or biologic agents. J Drugs Dermatol. 2012;11:1210-1217.
Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our cookie policy | Continue
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.